Grown Rogue International (GRUSF) Cash from Discontinued Operations (2011 - 2020)
Grown Rogue International's (GRUSF) quarterly Cash from Discontinued Operations came in at 120822.0 in Q2 2020, up 247.43% year-on-year from 34776.27 in Q2 2019, and down 19.66% quarter-over-quarter from 150384.0 in Q1 2020.
Grown Rogue International (GRUSF) Cash from Discontinued Operations (2011 - 2020) Analysis & Trends
Grown Rogue International's Cash from Discontinued Operations history runs 7 years deep, the most recent figure standing at 120822.0 for Q2 2020.
- On a quarterly basis, Cash from Discontinued Operations rose 247.43% year-over-year to 120822.0 in Q2 2020; TTM through Apr 2020 was 1979351.0, a 13.89% increase from a year earlier, with the FY2016 full-year figure at 4541.88, up 99.11% from the prior year.
- Cash from Discontinued Operations eased to 120822.0 in Q2 2020 per GRUSF's latest filing, from 150384.0 in the prior quarter.
- Across five years, Cash from Discontinued Operations topped out at 150384.0 in Q1 2020 and bottomed at 2168603.0 in Q1 2019.
- The 3-year median for Cash from Discontinued Operations is 23998.21 (2016), against an average of 337891.24.
- Across the five-year window, Cash from Discontinued Operations slumped 93.49% in 2016 and surged 247.43% in 2020, its largest moves.
- Year by year, Cash from Discontinued Operations stood at 4640.19 in 2016, then tumbled by 1866.18% to 81954.0 in 2019, then jumped by 247.43% to 120822.0 in 2020.
- Per Business Quant, the three latest GRUSF Cash from Discontinued Operations figures stand at 120822.0 (Q2 2020), 150384.0 (Q1 2020), and 81954.0 (Q2 2019).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Grown Rogue International | 99.97 Mn | 92.67 Mn | 3.96 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2020 | 120,822.00 |
| Apr 30, 2020 | 120,822.00 |
| Jan 31, 2020 | 150,384.00 |
| Jan 31, 2020 | 150,384.00 |
| Apr 30, 2019 | -81,954.00 |
| Apr 30, 2019 | -81,954.00 |
| Jan 31, 2019 | -2.17 Mn |
| Jan 31, 2019 | -2.17 Mn |
| Aug 31, 2016 | 4,640.19 |
| Aug 31, 2016 | 4,640.19 |
| May 31, 2016 | -52,636.62 |
| May 31, 2016 | -52,636.62 |
| Aug 31, 2015 | 71,229.11 |
| Aug 31, 2015 | 71,229.11 |
| Aug 31, 2014 | 44,579.42 |
| Aug 31, 2014 | 44,579.42 |
| Aug 31, 2013 | 51.10 |
| Aug 31, 2013 | 51.10 |
| Nov 30, 2011 | -338,963.09 |
| Nov 30, 2011 | -338,963.09 |